Lv2
130 积分 2023-09-22 加入
The cell surface glycoprotein CDCP1 in cancer—Insights, opportunities, and challenges
28天前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
28天前
已完结
Ansamer‐Controlled Bicyclic Peptides as Integrin αvβ6 Targeting Agents
3个月前
已完结
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
3个月前
已完结
In Vitro Selection of a Peptide Inhibitor of Human IL-6 Using mRNA Display
3个月前
已完结
Chemical Synthesis of Interleukin-6 for Mirror-Image Screening
3个月前
已完结
IBI3026, a first-in-class anti-PD-1/IL-12 fusion protein, demonstrates the potential to be a new immuno-oncology therapy by releasing the break in immune response and strongly activating T and NK cells in the tumor microenvironment
3个月前
已关闭
Abstract 3118: IBI3026, a first-in-class anti-PD-1/IL-12 fusion protein, demonstrates the potential to be a new immuno-oncology therapy by releasing the break in immune response and strongly activating T and NK cells in the tumor microenvironment
3个月前
已关闭
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement
4个月前
已完结
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
4个月前
已完结
皖公网安备34019202002308
